Update of the Mexican College of Rheumatology Guidelines for the Pharmacologic Treatment of Rheumatoid Arthritis

被引:33
|
作者
Cardiel, Mario H. [1 ]
Diaz-Borjon, Alejandro [2 ]
del Mercado Espinosa, Monica Vazquez [3 ,4 ,5 ]
Ivan Gamez-Nava, Jorge [4 ,6 ]
Barile Fabris, Leonor A. [7 ]
Pacheco Tena, Cesar [8 ]
Silveira Torre, Luis H. [9 ]
Pascual Ramosh, Virginia [10 ]
Goycochea Roblesi, Maria Victoria [11 ]
Aguilar Arreola, Jorge Enrique [3 ,4 ]
Gonzalez Diaz, Veronica [12 ]
Alvarez Nemegyei, Jose [13 ]
del Carmen Gonzalez-Lopez, Laura [4 ,14 ]
Salazar Paramon, Mario [15 ]
Portela Hernandez, Margarita [16 ]
Castro Colin, Zully [17 ]
Xibille Friedman, Daniel Xavier [18 ]
Alvarez Hernandez, Everardo [19 ]
Casasola Vargas, Julio [19 ]
Cortes Hernandez, Miguel [20 ]
Flores-Alvarado, Diana E. [21 ]
Martinez Martinez, Laura A. [22 ]
Vega-Morales, David [23 ]
Felipe Flores-Suarez, Luis [24 ]
Medrano Ramirez, Gabriel [25 ,26 ]
Barrera Cruz, Antonio [27 ,28 ]
Garcia Gonzalez, Adolfo [29 ]
Lopez Lopez, Susana Marisela [30 ]
Rosete Reyes, Alejandra [31 ]
Espinosa Morales, Rolando [32 ,33 ]
机构
[1] Hosp Gen Dr Miguel Silva, Secretaria Salud Michoacan, Unidad Invest Dr Mario Alvizouri Munoz, Morelia, Michoacan, Mexico
[2] UNAM, Hosp Angeles Lomas, Curso Especializac Med Interna, Huixquilucan, Estado De Mexic, Mexico
[3] Nuevo Hosp Civil Guadalajara Dr Juan I Menchaca, Guadalajara, Jalisco, Mexico
[4] Univ Guadalajara, Ctr Univ Ciencias Salud, Guadalajara, Jalisco, Mexico
[5] Univ Guadalajara, Ctr Univ Ciencias Salud, Inst Invest Reumatol & Sistema Musculo Esquelet, Guadalajara, Jalisco, Mexico
[6] UMAE, IMSS, Hosp Especialidades Ctr Med Nacl Occidente, Guadalajara, Jalisco, Mexico
[7] Dept Reumatol HE CMNSXXI IMSS, Mexico City, DF, Mexico
[8] Univ Autonoma Chihuahua, Fac Med, Chihuahua, Mexico
[9] Inst Nacl Cardiol Ignacio Chavez, Dept Reumatol, Curso Reumatol, Mexico City, DF, Mexico
[10] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Inmunol & Reumatol, Mexico City, DF, Mexico
[11] IMSS, Hosp Gen Reg Dr Carlos McGregor Sanchez Navarro 1, Unidad Invest Epidemiol Clin, Mexico City, DF, Mexico
[12] Antiguo Hosp Civil Guadalajara Fray Antonio Alcal, Guadalajara, Jalisco, Mexico
[13] Univ Anahuac Mayab, Escuela Med, Merida, Yucatan, Mexico
[14] Hosp Gen Reg 110 IMSS, Guadalajara, Jalisco, Mexico
[15] UMAE, Div Invest, Hosp Especialidades Ctr Med Nacl Occidente, IMSS, Guadalajara, Jalisco, Mexico
[16] Hosp Especialidades CMN SXXI, Dept Reumatol, Mexico City, DF, Mexico
[17] HGZ 27 IMSS, Dept Reumatol, Mexico City, DF, Mexico
[18] Hosp Gen Cuernavaca Dr Jose G Parres, Dept Reumatol, Cuernavaca, Morelos, Mexico
[19] Hosp Gen Mexico City, Mexico City, DF, Mexico
[20] Univ Autonoma Estado Morelos, Fac Med, Fisiol Humana, Cuernavaca, Morelos, Mexico
[21] Univ Autonoma Nuevo Leon, Hosp Univ Jose E Gonzalez, Med Interna & Reumatol, Monterrey, Nuevo Leon, Mexico
[22] Inst Nacl Cardiol Ignacio Chavez, Dept Reumatol, Mexico City, DF, Mexico
[23] Univ Autonoma Nuevo Leon, Hosp Univ Jose E Gonzalez, Monterrey, Nuevo Leon, Mexico
[24] Inst Nacl Enfermedades Resp, Clin Vasculitis Sistem Primarias, Mexico City, DF, Mexico
[25] Hosp Gen Mexico City, Serv Reumatol, Mexico City, DF, Mexico
[26] Consejo Mexicano Reumatol, Mexico City, DF, Mexico
[27] IMSS, Unidades Med Alta Especialidad, Programas Med, Mexico City, DF, Mexico
[28] IMSS, Unidades Med Alta Especialidad, Div Excelencia Clin, Area Desarrollo Guias Pract Clin Coordinac, Mexico City, DF, Mexico
[29] Hosp Gen Zona IMSS, Ciencias Med, La Paz, Baja California, Mexico
[30] Hosp Angeles del Carmen, Serv Reumatol, Guadalajara, Jalisco, Mexico
[31] Ctr Invest Farmacol & Biotecnol, Operac, Mexico City, DF, Mexico
[32] Univ Nacl Autonoma Mexico, Reumatol, Mexico City, DF, Mexico
[33] Inst Nacl Rehabil, Dept Reumatol, Mexico City, DF, Mexico
来源
REUMATOLOGIA CLINICA | 2014年 / 10卷 / 04期
关键词
Rheumatoid arthritis; Drug therapy; Adult; Arthritis medical care;
D O I
10.1016/j.reuma.2013.10.006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The pharmacologic management of rheumatoid arthritis has progressed substantially over the past years. It is therefore desirable that existing information be periodically updated. There are several published international guidelines for the treatment of rheumatoid arthritis that hardly adapt to the Mexican health system because of its limited healthcare resources. Hence, it is imperative to unify the existing recommendations and to incorporate them to a set of clinical, updated recommendations; the Mexican College of Rheumatology developed these recommendations in order to offer an integral management approach of rheumatoid arthritis according to the resources of the Mexican health system. Objective: To review, update and improve the available evidence within clinical practice guidelines on the pharmacological management of rheumatoid arthritis and produce a set of recommendations adapted to the Mexican health system, according to evidence available through December 2012. Methods: The working group was composed of 30 trained and experienced rheumatologists with a high quality of clinical knowledge and judgment. Recommendations were based on the highest quality evidence from the previously established treatment guidelines, meta-analysis and controlled clinical trials for the adult population with rheumatoid arthritis. Results: During the conformation of this document, each working group settled the existing evidence from the different topics according to their experience. Finally, all the evidence and decisions were unified into a single document, treatment algorithm and drug standardization tables. Conclusions: his update of the Mexican Guidelines for the Pharmacologic Treatment of Rheumatoid Arthritis provides the highest quality information available at the time the working group undertook this review and contextualizes its use for the complex Mexican health system. (C) 2013 Elsevier Espana, S.L.All rights reserved.
引用
收藏
页码:227 / 240
页数:14
相关论文
共 50 条
  • [21] Identifying factors associated with concordance with the American College of Rheumatology rheumatoid arthritis treatment recommendations
    Leslie R. Harrold
    George W. Reed
    Joel M. Kremer
    Jeffrey R. Curtis
    Daniel H. Solomon
    Marc C. Hochberg
    Arthur Kavanaugh
    Katherine C. Saunders
    Ying Shan
    Tanya M. Spruill
    Dimitrios A. Pappas
    Jeffrey D. Greenberg
    Arthritis Research & Therapy, 18
  • [22] Treatment Guidelines in Rheumatoid Arthritis
    Singh, Jasvinder A.
    RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2022, 48 (03) : 679 - 689
  • [23] Update of French society for rheumatology recommendations for managing rheumatoid arthritis
    Daien, Claire
    Hua, Charlotte
    Gaujoux-Viala, Cecile
    Cantagrel, Alain
    Dubremetz, Madeleine
    Dougados, Maxime
    Fautrel, Bruno
    Mariette, Xavier
    Nayral, Nathalie
    Richez, Christophe
    Saraux, Alain
    Thibaud, Gerard
    Wendling, Daniel
    Gossec, Laure
    Combe, Bernard
    JOINT BONE SPINE, 2019, 86 (02) : 135 - 150
  • [24] The Italian Society for Rheumatology clinical practice guidelines for rheumatoid arthritis
    Parisi, S.
    Bortoluzzi, A.
    Sebastiani, G. D.
    Conti, F.
    Caporali, R.
    Ughi, N.
    Prevete, I
    Ariani, A.
    Manara, M.
    Carrara, G.
    Scire, C. A.
    REUMATISMO, 2019, 71 : 22 - 49
  • [25] Criteria for improvement in rheumatoid arthritis: Alternatives to the American College of Rheumatology 20
    Albert, DA
    Huang, G
    Dubrow, G
    Brensinger, CM
    Berlin, JA
    Williams, HJ
    JOURNAL OF RHEUMATOLOGY, 2004, 31 (05) : 856 - 866
  • [26] Tofacitinib for the treatment of rheumatoid arthritis: an update
    Yamaoka, Kunihiro
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2019, 15 (06) : 577 - 588
  • [27] Japan College of Rheumatology guideline for the use of methotrexate in patients with rheumatoid arthritis
    Kameda, Hideto
    Fujii, Takao
    Nakajima, Ayako
    Koike, Ryuji
    Sagawa, Akira
    Kanbe, Katsuaki
    Tomita, Tetsuya
    Harigai, Masayoshi
    Suzuki, Yasuo
    MODERN RHEUMATOLOGY, 2019, 29 (01) : 31 - 40
  • [28] Folate supplementation during methotrexate treatment of patients with rheumatoid arthritis - An update and proposals for guidelines
    Endresen, GKM
    Husby, G
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2001, 30 (03) : 129 - 134
  • [29] Rituximab for the treatment of rheumatoid arthritis: an update
    Mok, Chi Chiu
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2014, 8 : 87 - 100
  • [30] Clinical assessment of the 1987 American College of Rheumatology criteria for rheumatoid arthritis
    Levin, RW
    Park, J
    Ostrov, B
    Reginato, A
    Baker, DG
    Bomalaski, JS
    Borofsky, M
    Gardiner, M
    Leventhal, L
    Louthrenoo, W
    vonFeldt, J
    Kolasinski, S
    Schumacher, HR
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 1996, 25 (05) : 277 - 281